In a report, the Government of Canada summarized a meeting of the Joint Sectoral Group on Pharmaceuticals. Topics included: ●
the Comprehensive Economic and Trade Agreement (CETA) GMP Protocol and related administrative arrangements ● recognition
of the Active Pharmaceutical Ingredients Program under the CETA GMP Protocol on Pharmaceuticals, and ● Canada’s proposal
on a mutual recognition agreement for drug facility inspections in third countries. Six administrative arrangements to facilitate the
effective implementation and monitoring of the CETA GMP Protocol were approved in principle and are expected to be adopted
early in 2019.